Your browser doesn't support javascript.
loading
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.
Oddo, Daniele; Siravegna, Giulia; Gloghini, Annunziata; Vernieri, Claudio; Mussolin, Benedetta; Morano, Federica; Crisafulli, Giovanni; Berenato, Rosa; Corti, Giorgio; Volpi, Chiara Costanza; Buscarino, Michela; Niger, Monica; Dunne, Philip D; Rospo, Giuseppe; Valtorta, Emanuele; Bartolini, Alice; Fucà, Giovanni; Lamba, Simona; Martinetti, Antonia; Di Bartolomeo, Maria; de Braud, Filippo; Bardelli, Alberto; Pietrantonio, Filippo; Di Nicolantonio, Federica.
Afiliación
  • Oddo D; Department of Oncology, University of Torino, Candiolo (TO) 10060, Italy.
  • Siravegna G; Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO) 10060, Italy.
  • Gloghini A; Department of Oncology, University of Torino, Candiolo (TO) 10060, Italy.
  • Vernieri C; Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO) 10060, Italy.
  • Mussolin B; FIRC Institute of Molecular Oncology (IFOM), Milan 20139, Italy.
  • Morano F; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
  • Crisafulli G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
  • Berenato R; Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO) 10060, Italy.
  • Corti G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
  • Volpi CC; Department of Oncology, University of Torino, Candiolo (TO) 10060, Italy.
  • Buscarino M; Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO) 10060, Italy.
  • Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
  • Dunne PD; Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO) 10060, Italy.
  • Rospo G; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
  • Valtorta E; Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO) 10060, Italy.
  • Bartolini A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
  • Fucà G; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7AE, UK.
  • Lamba S; Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO) 10060, Italy.
  • Martinetti A; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan 20162, Italy.
  • Di Bartolomeo M; Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO) 10060, Italy.
  • de Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
  • Bardelli A; Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO) 10060, Italy.
  • Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
  • Di Nicolantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy.
Br J Cancer ; 117(3): 347-352, 2017 Jul 25.
Article en En | MEDLINE | ID: mdl-28654634
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / ADN de Neoplasias / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met Tipo de estudio: Prognostic_studies Límite: Humans / Middle aged Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / ADN de Neoplasias / Protocolos de Quimioterapia Combinada Antineoplásica / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met Tipo de estudio: Prognostic_studies Límite: Humans / Middle aged Idioma: En Revista: Br J Cancer Año: 2017 Tipo del documento: Article País de afiliación: Italia